Mindpeak unveiled a new product to empower pathologists in detecting and grading prostate cancer.

We are looking forward to meeting you in person, at USCAP 2024, Baltimore (MD), USA. Meet our CEO Felix Faber and our experts Patrick Frey and Timm Goempel at our booth (no 863).

A refined approach for AI-assisted cancer diagnosis was developed by setting standards in the interpretation of scoring guidelines with a "PD-L1 Cell Atlas".

In a study investigating the efficiency gain in clinical routine with our AI Unilabs reported saving up to 90% diagnostic time compared to manual scoring. In addition, several patients needed to be re-classified leading to the identification of more patients eligible for treatment in the prospective study setting.

Our leading ‘0 Click’ AI algorithms are now available through Proscia’s Concentriq© platform used by Clinicians and Pharma R&D alike!

Our #ASCO2023 poster on HER2-low was selected for oral presentation by session chair Prof. David Rimm (Yale University School of Medicine). In his discussion he highlighted AI as an essential means to score HER2 in the future.